Professor Stavroula Sofou received a 4-year, $720,000 Research Scholar Grant from the American Cancer Society to design and evaluate a targeted liposomal antivascular alpha-particle therapeutic approach for the treatment of cancer. Professor Martin Yarmushserves as a consultant on this project, and the Center for Innovative Ventures of Emerging Technologies (CIVET) will assist the team in translating their work to the industrial and clinical arenas.